Healthcare Contract Manufacturing Market Size, Share & Trends Report

Healthcare Contract Manufacturing Market Size, Share & Trends Analysis Report By Type (Medical Devices, Pharmaceutical), By End-use (Medical Device Companies), By Region, And Segment Forecasts, 2023 - 2030

Report ID: GVR-3-68038-128-3
Number of Pages: 175
Format: Electronic (PDF)

Historical Range: 2018 - 2021
Industry: Healthcare

Market Segmentation

Healthcare Contract Manufacturing Type Outlook (Revenue, USD Billion, 2018 - 2030)
- Medical Devices
  - Service
    - Accessories manufacturing
    - Assembly manufacturing
    - Component manufacturing
    - Device manufacturing
  - Therapeutic Area
    - Cardiology
    - Diagnostic imaging
    - Orthopedic
    - IVD
    - Ophthalmic
    - General & plastic surgery
    - Drug delivery
    - Dental
    - Endoscopy
    - Diabetes care
    - Others
- Pharmaceutical
  - API/Bulk Drugs
  - Advanced drug delivery formulations
  - Packaging
  - Finished dose formulations
    - Solid
    - Liquid
    - Semi-solid formulations
Healthcare Contract Manufacturing End-use Outlook (Revenue, USD Billion, 2018 - 2030)
- Medical Device Companies
- Pharmaceutical & Biopharmaceutical Companies
- Others
Healthcare Contract Manufacturing Regional Outlook (Revenue, USD Billion, 2018 - 2030)
- North America
  - North America Healthcare Contract Manufacturing Market, By Type
    - Medical Devices
      - Service
        
        Accessories manufacturing
        
        Assembly manufacturing
        
        Component manufacturing
        
        Device manufacturing
      - Therapeutic Area
        
        Cardiology
        
        Diagnostic imaging
        
        Orthopedic
        
        IVD
        
        Ophthalmic
        
        General & plastic surgery
        
        Drug delivery
        
        Dental
        
        Endoscopy
        
        Diabetes care
        
        Others
    - Pharmaceutical
      - API/Bulk Drugs
      - Advanced drug delivery formulations
      - Packaging
      - Finished dose formulations
        
        Solid
        
        Liquid
        
        Semi-solid formulations
  - North America Healthcare Contract Manufacturing Market, By End use
    - Medical Device Companies
    - Pharmaceutical & Biopharmaceutical Companies
    - Others
  - U.S.
    - U.S. Healthcare Contract Manufacturing Market, By Type
      - Medical Devices
        
        Service
        
        Accessories manufacturing
        
        Assembly manufacturing
        
        Component manufacturing
        
        Device manufacturing
        
        Therapeutic Area
        
        Cardiology
        
        Diagnostic imaging
        
        Orthopedic
        
        IVD
        
        Ophthalmic
        
        General & plastic surgery
        
        Drug delivery
        
        Dental
        
        Endoscopy
        
        Diabetes care
        
        Others
      - Pharmaceutical
        
        API/Bulk Drugs
        
        Advanced drug delivery formulations
        
        Packaging
        
        Finished dose formulations
        
        Solid
        
        Liquid
        
        Semi-solid formulations
    - U.S. Healthcare Contract Manufacturing Market, By End use
      - Medical Device Companies
      - Pharmaceutical & Biopharmaceutical Companies
      - Others
  - Canada
    - Canada Healthcare Contract Manufacturing Market, By Type
      - Medical Devices
        
        Service
        
        Accessories manufacturing
        
        Assembly manufacturing
        
        Component manufacturing
        
        Device manufacturing
        
        Therapeutic Area
        
        Cardiology
        
        Diagnostic imaging
        
        Orthopedic
        
        IVD
        
        Ophthalmic
        
        General & plastic surgery
        
        Drug delivery
        
        Dental
        
        Endoscopy
        
        Diabetes care
        
        Others
      - Pharmaceutical
        
        API/Bulk Drugs
        
        Advanced drug delivery formulations
        
        Packaging
        
        Finished dose formulations
        
        Solid
        
        Liquid
        
        Semi-solid formulations
    - Canada Healthcare Contract Manufacturing Market, By End use
      - Medical Device Companies
      - Pharmaceutical & Biopharmaceutical Companies
      - Others
- Europe
- Asia Pacific
- Latin America
- Middle East & Africa

Healthcare Contract Manufacturing Market Market Dynamics

Drivers: Implementation Of International Standards By Contract Manufacturers

Contract manufacturers in developed regions such as the U.S., EU, and Japan adhere to international quality management system standards, making them more appealing than their counterparts in India and China. However, evolving regulations in these developing nations are ensuring that their contract manufacturers also comply. This regulatory compliance is anticipated to stimulate demand for various consulting services, including remediation, compliance, and Quality Management Systems (QMS), thereby fostering the growth of the global medical devices outsourcing market. For example, it is expected that the Good Manufacturing Practice (GMP) requirements for medical devices in India will align with the ISO 13485 quality management system. This alignment is likely to spur the demand for QMS services in India from Original Equipment Manufacturers (OEMs) and contract manufacturing firms, thereby propelling market growth.

Commercial Success Of Biologics For Clinical Use

The development of biological drugs has helped address issues related to the use of conventional synthetic drugs. Synthetic drugs, which are made from chemicals not naturally found in the human body, can cause side effects. As a result, biopharmaceutical firms are turning to biological processes to create biologics that target over 100 diseases. These biopharmaceuticals include monoclonal antibodies, vaccines, gene therapies, cell therapies, and more. The advent of biologics helps overcome the challenges associated with synthetic drugs/biosimilars, thereby increasing the demand for contract manufacturing services in the pharmaceutical sector. This growing demand for outsourcing biologics development services is due to the complex nature of biologics manufacturing. In addition to being complex, the manufacturing processes for biopharmaceuticals are sensitive and intricate. Even minor changes in factors such as temperature can affect the safety and effectiveness of the final product. These factors are expected to drive the growth of contract manufacturing services for biological production. In July 2020, GSK’s new Nucala formulation received FDA approval for treating adult and pediatric patients with Hypereosinophilic Syndrome (HES), making Nucala the first targeted biologic treatment approved for patients with this eosinophil-driven disease in the US. In 2020, the FDA’s Center for Drug Evaluation and Research (CDER) approved 53 new molecular entities and novel therapeutic biologics. In 2015, CDER approved 48 biotech drugs or biologics. These approvals demonstrate the success of biologics and biosimilars, which are expected to fuel the growth of the contract manufacturing and contract research services market in the forecast period. The need for higher potency, a new dose form, and biologic fill/finish by biologic manufacturers is expected to increase the adoption of contract services soon.

Restrains: Threat Of Information Loss

Original Equipment Manufacturers (OEMs) in the medical device sector are required to disclose confidential details about their products, partnerships, and contracts when they outsource to external vendors. This situation poses a risk of data theft or loss, which could negatively impact the OEMs’ business. As a result, many OEMs remain reluctant to embrace outsourcing as a cost-cutting strategy, which in turn, impedes market growth. The transfer of medical device designs also presents a risk. Medical devices have expanded beyond the confines of clinics and hospitals due to the increasing integration of the Internet in the medical field. This has spurred the development of wearable or portable medical devices, which fall under the category of Internet of Things (IoT) devices that transmit data via the internet. Consequently, these devices are vulnerable to cybersecurity threats, necessitating stringent design and development standards for their Printed Circuit Boards (PCBs). While safeguarding against unauthorized access to medical data is of utmost importance, it’s not the only security concern for medical devices. Most device design transfers to manufacturers are conducted online, either through email or data uploads, potentially exposing them to unauthorized access. This is expected to hinder market growth.

What Does This Report Include?

This section will provide insights into the contents included in this healthcare contract manufacturing market report and help gain clarity on the structure of the report to assist readers in navigating smoothly.

Healthcare contract manufacturing market qualitative analysis

Industry overview
Industry trends
Market drivers and restraints
Market size
Growth prospects
Porter’s analysis
PESTEL analysis
Key market opportunities prioritized
Competitive landscape
- Company overview
- Financial performance
- Product benchmarking
- Latest strategic developments

Healthcare contract manufacturing market quantitative analysis

Market size, estimates, and forecast from 2018 to 2030
Market estimates and forecast for product segments up to 2030
Regional market size and forecast for product segments up to 2030
Market estimates and forecast for application segments up to 2030
Regional market size and forecast for application segments up to 2030
Company financial performance

GET A FREE SAMPLE

This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself.

Or view our licence options:

NEED A CUSTOM REPORT?

We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports, as well as offer affordable discounts for start-ups & universities.

ESOMAR certified & member

ISO Certified

We are GDPR and CCPA compliant! Your transaction & personal information is safe and secure. For more details, please read our privacy policy.